Targeting Adaptive and Innate Immune Responses with Covalent Aptamers
Journal of the American Chemical Society · 19.08.2026 · 148 (32) · 34928-34937
DOI: 10.1021/jacs.6c10475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 10.08.2026. Verfasst von Savannah Albright und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania15260, United States. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Immunity, Innate, Adaptive Immunity, Receptor Protein-Tyrosine Kinases. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, University of Pittsburgh.
Abstract (Originalsprache)
Covalent aptamers have recently found initial success as tools for fast and selective transfer of labels to target proteins. Here, aptamers targeting protein tyrosine kinase 7 (PTK7) and the mesenchymal-epithelial transition factor (cMet) were functionalized with electrophiles capable of covalently transferring small-molecule immune recruiters. Capitalizing on biotin transfer, aptamers were utilized to trigger activation of universal anti-biotin chimeric antigen receptor (CAR) T cells resulting in selective lysis of PTK7- and cMet-positive cells. Additionally, a cleavable electrophile of 2,4-dinitrophenyl (DNP) hapten transfer was synthesized and utilized for the selective modification of cell surface PTK7 and cMet. The DNP modification elicited the selective activation of complement-dependent cytotoxicity (CDC). These results demonstrate the potential of covalent aptamers as immune-activating and cancer-cell-killing agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania15260, United States.
- Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania15213, United States.
- Institute for Synthetic Biology, University of Pittsburgh, Pittsburgh, Pennsylvania15260, United States.
ORCID-Profile: Avani Parikh, Michael Dorogan, Alexander Deiters
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- University of Pittsburgh
- National Institute of General Medical Sciences
Zitieren
APA
Albright, S., Parikh, A., Cacace, M., Rosenblum, C., Dorogan, M., Lohmueller, J., & Deiters, A. (2026). Targeting Adaptive and Innate Immune Responses with Covalent Aptamers. Journal of the American Chemical Society, 148(32), 34928-34937. https://doi.org/10.1021/jacs.6c10475
Vancouver
Albright S, Parikh A, Cacace M, Rosenblum C, Dorogan M, Lohmueller J, et al. Targeting Adaptive and Innate Immune Responses with Covalent Aptamers. Journal of the American Chemical Society. 2026;148(32):34928-34937. doi:10.1021/jacs.6c10475
BibTeX
@article{Albright2026,
author = {Albright, Savannah and Parikh, Avani and Cacace, Mary and Rosenblum, Carolyn and Dorogan, Michael and Lohmueller, Jason and Deiters, Alexander},
title = {Targeting Adaptive and Innate Immune Responses with Covalent Aptamers},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {32},
pages = {34928--34937},
doi = {10.1021/jacs.6c10475}
}
EUVIMED